» Articles » PMID: 25261293

Racial Disparities in Risk of Second Breast Tumors After Ductal Carcinoma in Situ

Overview
Specialty Oncology
Date 2014 Sep 28
PMID 25261293
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of the study was to examine the impact of race/ethnicity on second breast tumors among women with ductal carcinoma in situ (DCIS). We identified 102,489 women diagnosed with primary DCIS between 1988 and 2009 from the 18 NCI-SEER Registries. Cox proportional hazard regression was used to estimate race/ethnicity-associated relative risks (RRs) and their 95 % confidence intervals (CI) of ipsilateral breast tumors (IBT; defined as DCIS or invasive carcinoma in the ipsilateral breast) and contralateral breast tumors (CBT; defined as DCIS or invasive carcinoma in the contralateral breast). Overall, 2,925 women had IBT and 3,723 had CBT. Compared with white women, black (RR 1.46; 95 % CI 1.29-1.65), and Hispanic (RR 1.18; 95 % CI 1.03-1.36) women had higher IBT risk, which was similar for invasive IBT and ipsilateral DCIS. A significant increase in IBT risk among black women persisted, regardless of age at diagnosis, treatment, tumor grade, tumor size, and histology. The CBT risk was significantly increased among black (RR 1.21; 95 % CI 1.08-1.36) and Asian/PI (RR 1.16; 95 % CI 1.02-1.31) women compared with white women. The association was stronger for invasive CBT among black women and for contralateral DCIS among Asian/PI women (P heterogeneity < 0.0001). The black race-associated CBT risk was more pronounced among women ≥50 years at diagnosis and those with comedo DCIS; in contrast, a significant increase in risk among Asian/PI women was restricted to those <50 years and those with noncomedo DCIS. Racial/ethnic differences in risks of second breast tumors after DCIS could not be explained by pathologic features and treatment.

Citing Articles

From ductal carcinoma in situ to invasive breast cancer: the prognostic value of the extracellular microenvironment.

Hulahan T, Angel P J Exp Clin Cancer Res. 2024; 43(1):329.

PMID: 39716322 PMC: 11664872. DOI: 10.1186/s13046-024-03236-z.


Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome.

Strand S, Houlahan K, Branch V, Lynch T, Rivero-Guitierrez B, Harmon B Breast Cancer Res. 2024; 26(1):127.

PMID: 39223670 PMC: 11367816. DOI: 10.1186/s13058-024-01885-8.


Extracellular Microenvironment Alterations in Ductal Carcinoma In Situ and Invasive Breast Cancer Pathologies by Multiplexed Spatial Proteomics.

Hulahan T, Spruill L, Wallace E, Park Y, West R, Marks J Int J Mol Sci. 2024; 25(12).

PMID: 38928454 PMC: 11203487. DOI: 10.3390/ijms25126748.


Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast.

Badve S, Cho S, Lu X, Cao S, Ghose S, Thike A Cancers (Basel). 2022; 14(16).

PMID: 36010908 PMC: 9406008. DOI: 10.3390/cancers14163916.


Disaggregation of Asian American and Pacific Islander Women With Stage 0-II Breast Cancer Unmasks Disparities in Survival and Surgery-to-Radiation Intervals: A National Cancer Database Analysis From 2004 to 2017.

Taparra K, Dee E, Dao D, Patel R, Santos P, Chino F JCO Oncol Pract. 2022; 18(8):e1255-e1264.

PMID: 35594493 PMC: 9377694. DOI: 10.1200/OP.22.00001.


References
1.
Kerlikowske K, Molinaro A, Cha I, Ljung B, Ernster V, Stewart K . Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst. 2003; 95(22):1692-702. DOI: 10.1093/jnci/djg097. View

2.
Glynn R, Rosner B . Methods to evaluate risks for composite end points and their individual components. J Clin Epidemiol. 2004; 57(2):113-22. DOI: 10.1016/j.jclinepi.2003.02.001. View

3.
Ernster V, Ballard-Barbash R, Barlow W, Zheng Y, Weaver D, Cutter G . Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002; 94(20):1546-54. DOI: 10.1093/jnci/94.20.1546. View

4.
Ward E, Jemal A, Cokkinides V, Singh G, Cardinez C, Ghafoor A . Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54(2):78-93. DOI: 10.3322/canjclin.54.2.78. View

5.
Zhou W, Jirstrom K, Johansson C, Amini R, Blomqvist C, Agbaje O . Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study. BMC Cancer. 2010; 10:653. PMC: 3001723. DOI: 10.1186/1471-2407-10-653. View